BIOSYNTIA
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We par... tner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
BIOSYNTIA
Industry:
Biopharma Biotechnology Clinical Trials Manufacturing
Founded:
2012-01-01
Address:
Hørsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.biosyntia.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - Biosyntia
European Circular Bioeconomy Fund
European Circular Bioeconomy Fund investment in Series B - Biosyntia
Novo Holdings
Novo Holdings investment in Series B - Biosyntia
Novo Holdings
Novo Holdings investment in Series A - Biosyntia
Sofinnova Partners
Sofinnova Partners investment in Series A - Biosyntia
Novo Ventures
Novo Ventures investment in Seed Round - Biosyntia
Novo Holdings
Novo Holdings investment in Seed Round - Biosyntia
Official Site Inspections
http://www.biosyntia.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.71 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Biosyntia"
A Natural Alternative - Biosyntia
Biosyntia was founded by Morten Sommer, Hans Genee and Andreas Hougaard Laustsen as a spin-out from the Centre for Biosustainability, at the Technical University of Denmark. Today we are 20 passionate people with capabilities …See details»
Biosyntia - Crunchbase Company Profile & Funding
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by …See details»
Biosyntia
Nature's ingredients...sustainably produced. Who we are. About BiosyntiaSee details»
Biosyntia 2025 Company Profile: Valuation, Funding & Investors
Biosyntia General Information Description. Developer of a fermentation-based platform intended to produce natural active ingredients for various applications. The company offers a …See details»
Biosyntia - VentureRadar
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high …See details»
Biosyntia - 2025 Company Profile - Tracxn
Mar 22, 2025 Biosyntia has raised a total funding of $23.4M over 8 rounds. Its first funding round was on Jan 01, 2015. Its latest funding round was a Series B round on Jul 06, 2022 for …See details»
Biosyntia - Contacts, Employees, Board Members, Advisors & Alumni
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.See details»
Biosyntia Company Profile - Office Locations, Competitors ... - Craft
Biosyntia is a biotech company that specializes in synthetic biology and metabolic engineering. It produces B-vitamins and selected nutraceuticals from renewable sugar using a biological …See details»
Biosynthia - Protein Directory
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing …See details»
Biosyntia ApS | DANISH BIO - Dansk Biotek
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. The company develops biocatalysts at an unprecedented speed and efficiency by employing its patent …See details»
Biosyntia — Sofinnova Partners
Biosyntia is an industrial biotech company developing bio-based manufacturing processes with core capabilities within strain engineering and fermentation. The company was founded in …See details»
Our uniqueness - Biosyntia
We build full processes and deliver the ingredient Biosyntia is a product company, and we consider our technology as a critical tool to deliver dietary ingredients with added value. We …See details»
Biosyntia Company Information - Funding, Investors, and More
The company Biosyntia has raised a total of $11.64m in funding over 1 rounds. Key Insights: Series B: $11.64m; 2022. Biosyntia Series B (2022, $11M) $11.64m. Similar startup. Reshape …See details»
Biosyntia - The Hub
Biosyntia ia a biotech start-up, which was founded by Morten Sommer, Hans Genee and Andreas Hougaard Laustsen as a spin-out from the Centre for Biosustainability, at the Technical …See details»
Biotech start-up raising DKK 130 million to produce natural …
Sep 30, 2022 The investment from EIFO, among others, will help to start the production and ensure that Biosyntia’s first commercial product lands in the consumers’ shopping cart. …See details»
NEW Press relaese - Biosyntia
January 2022 – Danish biotech company Biosyntia and the Munich-based WACKER Group today announced the signing of a contract to develop a large-scale production process for …See details»
Biosyntia raises €4 million in Series A financing to advance its ...
Biosyntia has today announced a Series A investment in the company of 4 million euros from Sofinnova Partners, a new investor, and Novo Seeds, an existing investor. The investment will …See details»
Biosyntia closes a 11.5 million EUR round to launch world
Jul 7, 2022 Biosyntia is an industrial biotech company delivering nature’s ingredients at scale both affordably and sustainably. Using cutting-edge biotechnology and proprietary R&D tools …See details»
Biosyntia closes a 11.5 million EUR round to launch world’s first bio ...
Jul 7, 2022 About Biosyntia Biosyntia is an industrial biotech company developing bio-based manufacturing processes with all critical capabilities for success in-house – stretching from …See details»
Biosyntia closes a €11.5 million round to launch world’s first bio ...
Jul 7, 2022 Biosyntia is an industrial biotech company developing bio-based manufacturing processes with all critical capabilities for success inhouse – stretching from microbial …See details»